Companies / Oruka Therapeutics, Inc. / Activity
Activity — Oruka Therapeutics, Inc.
46 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Sandler Laura Lee Executive | Sell | Common Stock | $246.4K | -9K -4.01% | 209,336 0.32% of shares | medium |
| Feb 17, 2026 | Goncalves Joana Executive | Sell | Common Stock | $195.9K | -6K -14.78% | 34,954 0.05% of shares | medium |
| Jan 15, 2026 | Goncalves Joana Executive | Sell | Common Stock | $138.3K | -4K -51.43% | 4,137 <0.01% of shares | medium |
| Mar 16, 2026 | Goncalves Joana Executive | Sell | Common Stock | $119.6K | -3K -7.62% | 35,195 0.05% of shares | medium |
| Mar 16, 2026 | Goncalves Joana Executive | Sell | Common Stock | $117.2K | -3K -7.12% | 38,097 0.06% of shares | medium |
| Jan 2, 2026 | Sandler Laura Lee Executive | Sell | Common Stock | $91.4K | -3K -1.50% | 206,192 0.31% of shares | low |
| Mar 2, 2026 | Sandler Laura Lee Executive | Sell | Common Stock | $90.4K | -3K -1.11% | 237,584 0.36% of shares | low |
| Jan 15, 2026 | Goncalves Joana Executive | Sell | Common Stock | $84.4K | -3K -63.31% | 1,518 <0.01% of shares | low |
| Mar 2, 2026 | Sandler Laura Lee Executive | Sell | Common Stock | $77.4K | -2K -0.96% | 240,259 0.36% of shares | low |
| Mar 16, 2026 | Klein Lawrence Otto CEO | Sell | Common Stock | $71.4K | -2K -0.19% | 927,309 1.40% of shares | low |
| Jun 15, 2026 | Quinlan Paul T Executive | Sell | Common Stock | $51.1K | -733 -2.31% | 31,034 0.05% of shares | low |
| Mar 16, 2026 | Goncalves Joana Executive | Sell | Common Stock | $49.4K | -1K -3.34% | 34,018 0.05% of shares | low |
| Mar 2, 2026 | Sandler Laura Lee Executive | Exercise | Common Stock | $39.0K | +5K +2.10% | 242,584 0.37% of shares | low |
| Jan 2, 2026 | Sandler Laura Lee Executive | Exercise | Common Stock | $39.0K | +5K +2.35% | 218,084 0.33% of shares | low |
| Jan 2, 2026 | Sandler Laura Lee Executive | Sell | Common Stock | $33.0K | -1K -0.54% | 205,084 0.31% of shares | low |
| Feb 17, 2026 | Goncalves Joana Executive | Sell | Common Stock | $30.7K | -936 -2.68% | 34,018 0.05% of shares | low |
| Mar 16, 2026 | Quinlan Paul T Executive | Sell | Common Stock | $30.3K | -733 -2.26% | 31,767 0.05% of shares | low |
| Mar 16, 2026 | Goncalves Joana Executive | Exercise | Common Stock | $27.3K | +4K +9.33% | 41,018 0.06% of shares | low |
| Feb 17, 2026 | Goncalves Joana Executive | Exercise | Common Stock | $27.3K | +4K +9.33% | 41,018 0.06% of shares | low |
| Jan 15, 2026 | Goncalves Joana Executive | Exercise | Common Stock | $27.3K | +4K +69.75% | 8,518 0.01% of shares | low |
| Mar 16, 2026 | Goncalves Joana Executive | Sell | Common Stock | $26.5K | -641 -1.88% | 33,377 0.05% of shares | low |
| Mar 16, 2026 | Sandler Laura Lee Executive | Sell | Common Stock | $24.8K | -600 -0.25% | 236,984 0.36% of shares | low |
| Mar 16, 2026 | Goncalves Joana Executive | Exercise | Common Stock | $23.9K | +4K +10.29% | 37,518 0.06% of shares | low |
| Feb 17, 2026 | Goncalves Joana Executive | Exercise | Common Stock | $23.9K | +4K +10.29% | 37,518 0.06% of shares | low |
| Jan 15, 2026 | Goncalves Joana Executive | Exercise | Common Stock | $23.9K | +4K +230.57% | 5,018 <0.01% of shares | low |
| Mar 16, 2026 | Agarwal Arjun Executive | Sell | Common Stock | $16.3K | -395 -2.05% | 18,863 0.03% of shares | low |
| Jan 23, 2026 | Sandler Laura Lee Executive | Grant | Common Stock | $0 | +33K +15.85% | 237,584 0.36% of shares | low |
| Jan 23, 2026 | Agarwal Arjun Executive | Grant | Common Stock | $0 | +18K +995.45% | 19,258 0.03% of shares | low |
| Jan 23, 2026 | Dambkowski Carl Director | Other | Common Stock | $0 | +116K | 116,483 0.18% of shares | low |
| Jan 23, 2026 | Klein Lawrence Otto CEO | Grant | Common Stock | $0 | +77K +9.00% | 929,038 1.40% of shares | low |
| Jan 23, 2026 | Goncalves Joana Executive | Grant | Common Stock | $0 | +33K +2140.97% | 34,018 0.05% of shares | low |
| Jan 23, 2026 | Quinlan Paul T Executive | Grant | Common Stock | $0 | +33K | 32,500 0.05% of shares | low |
| Jun 2, 2026 | Ball Kristine M Director | Grant | Stock Option (right to buy) | — | +9K | 9,136 0.01% of shares | low |
| Mar 2, 2026 | Sandler Laura Lee Executive | Exercise | Employee Warrant (right to buy) | — | -5K -5.26% | 89,996 0.14% of shares | low |
| Jan 23, 2026 | Sandler Laura Lee Executive | Grant | Employee Stock Option (right to buy) | — | +130K | 130,000 0.20% of shares | low |
| Jan 2, 2026 | Sandler Laura Lee Executive | Exercise | Employee Warrant (right to buy) | — | -5K -5.00% | 94,996 0.14% of shares | low |
| Jan 23, 2026 | Agarwal Arjun Executive | Grant | Employee Stock Option (right to buy) | — | +70K | 70,000 0.11% of shares | low |
| Jan 23, 2026 | Klein Lawrence Otto CEO | Grant | Employee Stock Option (right to buy) | — | +307K | 306,700 0.46% of shares | low |
| Mar 16, 2026 | Goncalves Joana Executive | Exercise | Employee Warrant (right to buy) | — | -4K -1.85% | 185,992 0.28% of shares | low |
| Mar 16, 2026 | Goncalves Joana Executive | Exercise | Employee Stock Option (right to buy) | — | -4K -1.60% | 214,563 0.32% of shares | low |
| Feb 17, 2026 | Goncalves Joana Executive | Exercise | Employee Warrant (right to buy) | — | -4K -1.81% | 189,492 0.29% of shares | low |
| Feb 17, 2026 | Goncalves Joana Executive | Exercise | Employee Stock Option (right to buy) | — | -4K -1.58% | 218,063 0.33% of shares | low |
| Jan 23, 2026 | Goncalves Joana Executive | Grant | Employee Stock Option (right to buy) | — | +130K | 130,000 0.20% of shares | low |
| Jan 15, 2026 | Goncalves Joana Executive | Exercise | Employee Warrant (right to buy) | — | -4K -1.78% | 192,992 0.29% of shares | low |
| Jan 15, 2026 | Goncalves Joana Executive | Exercise | Employee Stock Option (right to buy) | — | -4K -1.56% | 221,563 0.33% of shares | low |
| Jan 23, 2026 | Quinlan Paul T Executive | Grant | Employee Stock Option (right to buy) | — | +130K | 130,000 0.20% of shares | low |